YUTIQ® (fluocinolone acetonide intravitreal implant) 0.18 mg is indicated for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye.

Patient 2

2-Month Follow-up After YUTIQ Treatment

Presentation at 2-Month Follow-up

IOP12 mmHg
Vitreous cellClear
Fundus exam findingsCME reduced
Continue to monitor for IOP elevations and inflammation recurrence.

Imaging at 2-Month Follow-up